Charmacy Pharmaceutical Signs New Agreements with Jiangyao

Charmacy Pharmaceutical Co., Ltd. Class H (HK:2289) has released an update.

Charmacy Pharmaceutical Co., Ltd. has entered into new framework agreements with Jiangyao Group to continue trading in medicines, medical devices, and healthcare products. The agreements, which involve significant shareholder participation, are subject to approval under listing rules due to their substantial financial ratios. An independent board and financial adviser have been appointed to ensure fairness and transparency in these transactions.

For further insights into HK:2289 stock, check out TipRanks’ Stock Analysis page.